戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1         VAT (-22%), intrahepatic (-29%), and intrapericardial (-11%) fats declines were higher than p
2 cardial procaine treatment and eliminated by intrapericardial A-317491, a selective P2X(2/3) and P2X(
3            With x-ray/MR imaging, successful intrapericardial access and delivery were achieved in al
4                                              Intrapericardial administration allows investigation of
5 age, hypertrophied animals were treated with intrapericardial administration of recombinant VEGF prot
6 nt and fifty percent of neurons responded to intrapericardial algogenic chemicals (0.2 ml) in male an
7                                              Intrapericardial alpha,beta-meATP also evoked CSR respon
8                   We compared the effects of intrapericardial and intracoronary nitroglycerin on coro
9 the low-fat diet in decreasing intrahepatic, intrapericardial, and pancreatic fats (P<0.05 for all).
10                                              Intrapericardial bradykinin (IB) altered activity of 58/
11  The number of cuneate neurons responding to intrapericardial bradykinin (IB, 15.6%, 17/109) was sign
12     We compared a newer LVAD design (a small intrapericardial centrifugal-flow device) against existi
13 eligible for heart transplantation, a small, intrapericardial, centrifugal-flow LVAD was found to be
14 /311 (31%) neurons responded to both TED and intrapericardial chemicals (IC) and 48/177 (27%) neurons
15 f 55 (27%) superficial neurons responsive to intrapericardial chemicals were compared to 80/169 (47%)
16 nd for 77/95 (81%) neurons that responded to intrapericardial chemicals.
17 ular exposure of coronary arteries to NO via intrapericardial D-BSA administration reduced flow-restr
18                      Ablation was limited by intrapericardial defibrillator patches adherent to the l
19              With x-ray/MR imaging guidance, intrapericardial delivery can be performed safely in the
20                                              Intrapericardial delivery of angiogenic factors may offe
21                                              Intrapericardial delivery of BaCaps with hMSCs leads to
22 d coronary vasodilation can be achieved with intrapericardial delivery of nitroglycerin without syste
23                        The data suggest that intrapericardial delivery of NO donors for which NO rele
24 onatal mice (age, 2 days; n = 131) underwent intrapericardial delivery of recombinant adenoviruses en
25 imaging 1 week after x-ray/MR imaging-guided intrapericardial delivery showed no evidence of pericard
26 obilization are sparse.We sought to evaluate intrapericardial-fat (IPF) and extrapericardial-fat (EPF
27          Collectively, our study establishes intrapericardial injection as a safe and effective metho
28 strate the feasibility of minimally-invasive intrapericardial injection in a clinically-relevant porc
29 f myocardial infarction, we demonstrate that intrapericardial injection is an effective and safe meth
30                             We observed that intrapericardial injection of alpha,beta-methylene ATP (
31                                              Intrapericardial injection of D-BSA immediately before 3
32                                              Intrapericardial injection of EVs improved adverse myoca
33 d" for in situ cardiac patch formation after intrapericardial injection of therapeutics in biocompati
34 ng pathway) with a favorable delivery route (intrapericardial injection) for cardiac repair.
35 creased in six out of six neurons excited by intrapericardial injections.
36 s with steroids (13.2%, 10.0%, and 29.4% for intrapericardial, intravenous or oral, and none, respect
37 G with steroids (36.8%, 30.0%, and 41.2% for intrapericardial, intravenous or oral, and none, respect
38                               Catheter-based intrapericardial (IPC) delivery of therapeutic agents ha
39 nd histopathology of a percutaneously placed intrapericardial lead (IPL).
40 ared 53 patients who received postprocedural intrapericardial liposomal bupivacaine (LB)+oral colchic
41 ptor-mediated CSR responses were enhanced by intrapericardial naloxone, a specific opioid receptor an
42                                              Intrapericardial nitroglycerin (200 microg) was administ
43 e investigated the antiarrhythmic effects of intrapericardial nitroglycerin (NTG) during acute myocar
44                                              Intrapericardial nitroglycerin was associated with a mea
45 ved at 3 min with intracoronary but not with intrapericardial nitroglycerin.
46 icular pressure by dobutamine was blunted by intrapericardial NTG (from 3,999 +/- 196 mm Hg/s before
47                                              Intrapericardial NTG exerts a robust antifibrillatory ac
48                                              Intrapericardial NTG suppressed VF at 45 min in all six
49 ctions in pump size, centrifugal design, and intrapericardial positioning may reduce complications an
50                                  Addition of intrapericardial postprocedural LB to oral colchicine in
51 ompliance, which are exacerbated by elevated intrapericardial pressure.
52 blockade of cardiac neural transmission with intrapericardial procaine treatment and eliminated by in
53  are more effective when administered by the intrapericardial rather than intravascular route.
54 efore and during apnea, and before and after intrapericardial RTX administration (protocol 2, n=9).
55 eparations, the device was inserted into the intrapericardial space through a subxiphoid approach.
56  last 38 procedures (44.7%) were followed by intrapericardial steroid injection.
57 itic chest pain was significantly reduced by intrapericardial steroids (58.8% versus 21.1%; P=0.006)
58 tic chest pain is significantly decreased by intrapericardial steroids.
59 sed for c-fos immunohistochemistry following intrapericardial stimulation with mechanical, chemical,